Gyl Financial Synergies, LLC Illumina, Inc. Transaction History

Gyl Financial Synergies, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$181.58 - $368.0 $131,282 - $266,064	-723 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$303.87 - $423.8 $21,574 - $30,089	-71 Reduced 8.94%	723 $253,000
Q4 2021 Feb 08, 2022	BUY	$347.28 - $421.83 $32,991 - $40,073	95 Added 13.59%	794 $302,000
Q2 2021 Aug 02, 2021	SELL	$372.84 - $481.5 $18,642 - $24,075	-50 Reduced 6.68%	699 $331,000
Q1 2021 May 04, 2021	SELL	$361.28 - $504.76 $5,419 - $7,571	-15 Reduced 1.96%	749 $288,000
Q3 2020 Nov 06, 2020	BUY	$268.51 - $400.74 $34,637 - $51,695	129 Added 20.31%	764 $236,000
Q2 2020 Aug 04, 2020	BUY	$256.46 - $373.01 $162,852 - $236,861	635 New	635 $235,000
Q1 2020 May 05, 2020	SELL	$209.2 - $335.53 $148,532 - $238,226	-710 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$288.29 - $335.49 $5,765 - $6,709	20 Added 2.9%	710 $236,000
Q1 2019 May 21, 2019	SELL	$272.57 - $321.18 $30,255 - $35,650	-111 Reduced 13.86%	690 $214,000
Q1 2019 May 14, 2019	BUY	$272.57 - $321.18 $30,255 - $35,650	111 Added 16.09%	801 $249,000
Q4 2018 Feb 14, 2019	BUY	$272.46 - $366.54 $187,997 - $252,912	690 New	690 $207,000

900

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.3B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Gyl Financial Synergies, LLC, based on Form 13F filings with the SEC.

Stay updated on Gyl Financial Synergies, LLC with notifications on news.